Patent · US Active

Materials and methods for controlling vasculogenesis from endothelial colony forming cells

US10828337B2 · kind B2 · utility

0Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 7, 2018
Grant dateNov 10, 2020
Priority date
Expiry dateMar 7, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L27/3808
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Materials and methods are disclosed for controlling vasculogenesis using building blocks of a collagen matrix and endothelial colony forming cells (ECFC). The building blocks may be isolated by fractionating an acid soluble Type I collagen. The building blocks comprising monomers and/or oligomers may be recombined in desired ratios to alter the matrix microenvironment and to influence ECFC behavior.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.